Deepflare

About:

Deepflare is an AI company helping pharma firms accelerate cancer vaccine and immunotherapy development.

Top Investors: Sunfish Partners, Lemonade Stand, National Center for Research & Development, Polish Development Fund, Szymon Sypniewicz

Description:

Deepflare is a techbio AI company providing an ML suite to pharma firms to accelerate cancer vaccine and immunotherapy development. The model predicts T-cell responses and identifies key epitopes, enhancing antigen immunogenicity, speeding up pre-clinical research, reducing costs and improving efficacy.

Total Funding Amount:

1.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Warsaw, Mazowieckie, Poland

Founded Date:

2020-01-01

Contact Email:

contact(AT)deepflare.ai

Founders:

Grzegorz Preibisch, Piotr Grzegorczyk, Stanisław Giziński

Number of Employees:

1-10

Last Funding Date:

2022-07-26

IPO Status:

Private

Industries: